IDEXX Laboratories (IDXX) is a publicly traded Healthcare sector company. As of October 3, 2026, IDXX trades at $518.47 with a market cap of $40.79B and a P/E ratio of 36.35. IDXX moved +0.14% today. Year to date, IDXX is -22.63%; over the trailing twelve months it is -18.21%. Its 52-week range spans $356.14 to $769.98. Analyst consensus is buy with an average price target of $699.17. Rallies surfaces IDXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for IDXX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $518.47 |
| Market Cap | $40.79B |
| P/E Ratio | 36.35 |
| EPS | $14.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $769.98 |
| 52-Week Low | $356.14 |
| Volume | 195.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.55B |
| Net Income | $1.14B |
| Gross Margin | 62.45% |
7 analysts cover IDXX: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $699.17.